Literature DB >> 13642277

The antagonisms of atropine to the EEG effects of adrenergic drugs.

R P WHITE, E A DAIGNEAULT.   

Abstract

Entities:  

Keywords:  ATROPINE/effects; ELECTROENCEPHALOGRAPHY/effect of drugs on; SYMPATHOMIMETICS/antagonists

Mesh：

Substances：

Year:  1959        PMID： 13642277

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  6 in total

1.  The pharmacological characteristics of neurons participating in tremor formation.

Authors:  V B PROZOROVSKII
Journal:  Biull Eksp Biol Med       Date:  1962-05

2.  The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.

Authors:  Luigi Taranto-Montemurro; Ludovico Messineo; Scott A Sands; Ali Azarbarzin; Melania Marques; Bradley A Edwards; Danny J Eckert; David P White; Andrew Wellman
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

3.  [On the problem of the effects on the central nervous system of toxic doses of atropine].

Authors:  H Higuchi; L Lendle
Journal:  Arch Toxikol       Date:  1966

4.  Effects of some sympathomimetic drugs and their antagonists on afterdischarges elicited in chronically isolated slabs of cerebral cortex.

Authors:  G Krip; J Vázquez
Journal:  Br J Pharmacol       Date:  1971-12       Impact factor: 8.739

5.  Effect of Venlafaxine on Apnea-Hypopnea Index in Patients With Sleep Apnea: A Randomized, Double-Blind Crossover Study.

Authors:  Christopher N Schmickl; Yanru Li; Jeremy E Orr; Rachel Jen; Scott A Sands; Bradley A Edwards; Pamela DeYoung; Robert L Owens; Atul Malhotra
Journal:  Chest       Date:  2020-04-09       Impact factor: 10.262

Review 6.  Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature.

Authors:  Luigi Taranto-Montemurro; Ludovico Messineo; Andrew Wellman
Journal:  J Clin Med       Date:  2019-11-02       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.